National Multiple Sclerosis and Epilepsy Act
Latest action. Referred to House Committee on Interstate and Foreign Commerce.
National Multiple Sclerosis and Epilepsy Act - Expresses the findings of Congress and declares the purpose of this Act. Instructs the Director of the National Institute of Neurological Diseases and Stroke to develop a neurological disease program to expand, intensify and coordinate the activities of the Institute. Specifies the scope of such program. Requires the Director to report annually on the accomplishments of the program. Empowers the Director to: (1) obtain the services of 50 experts; (2) acquire and maintain neurological disease equipment and facilities; and (3) enter into contracts to carry out the purposes of this Act. Authorizes appropriations of such sums as necessary to carry out the above objectives. Instructs the Director to develop six new centers for multiple sclerosis research and treatment and 14 new centers for other neurological and sensory diseases. Authorizes appropriations of $100 million, $125 million, and $150 million for such purposes for fiscal years 1973-1975. Empowers the Director to make grants to public entities for research in neurological disorders and authorizes to be appropriated such sums as necessary for such purposes.
Written by analysts at the Congressional Research Service and published on Congress.gov, not by Civibrief. Summarized at the "Introduced in House" stage on October 2, 1974. It describes the bill, it is not the legal text.
Where is it in the process, and what happens next?
4 steps remain before this bill could become law.
The record's latest action, on October 2, 1974: Referred to House Committee on Interstate and Foreign Commerce.
- Clearing the committees it was referred to, and being scheduled for a floor vote
- Passage by the House
- Passage by the Senate
- The President's signature. If the President vetoes it, two-thirds of both chambers must vote to override.
How likely is it to become law?
Civibrief does not forecast outcomes and this page has no opinion about this one. What the record supports is a base rate, which is a fact about the whole pile, not a prediction about this measure.
In the 93rd Congress (1973-74), 651 of the 23,396 bills and joint resolutions introduced became law, about 2.8 percent. That count covers every measure at every stage, including the many that never left committee.
This one is not there yet: 4 steps are still outstanding, listed above.
Has anyone actually voted on it?
No. No roll call in this Congress cites this measure. That is the ordinary outcome: most measures never reach a recorded floor vote, and a committee ends most of them simply by not acting.
A vote is not the only thing that happens to a measure. Hearings, markups, and referrals are all recorded actions, and none of them is a vote of the full chamber.
Who is behind it?
MARVIN ESCH (R-MI) introduced it on October 2, 1974. No cosponsors are recorded.
Cosponsoring is a formal signature on the text. It is not a commitment to vote for the measure, it does not bind anyone's party, and a long list of cosponsors is a measure of attention rather than of prospects.
How long has it been in play?
It was introduced on October 2, 1974, 18971 days ago. The most recent recorded action was 18971 days ago, on October 2, 1974.
Measures do not carry over. Anything the 93rd Congress has not finished by January 3, 1975 dies when the term ends, and has to be introduced again from the start in the next Congress.
Every answer above is assembled from this measure's own record on Congress.gov and from published counts of what Congress has passed before. Civibrief does not predict outcomes and takes no position on any measure.
Vote history
- HouseIn committee, no floor vote yet
- SenateAwaits House passage
- PresidentAwaits both chambers